logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
K

Kelly Foster

Griffith University

13H-index
58Paper Count
928Citation Count
Published Papers 6
Publication Date
logo
Preclinical pharmacology, pharmacokinetics, and pharmacodynamics of veligrotug, a full antagonist antibody to the IGF-1 receptor in development for thyroid eye disease
errMABS
IF7.3
err2025-12-31
err0
PREAI
errKaplan, Rachel; Zhao, Yang; Tsai, Jordan; Dickinson, Brent; Swanson, Tyler; Foster, Kelly; Bedian, Vahe
errShare
errSave
A Phase 1 Single-Ascending-Dose Trial in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravenous PNT001, a Novel Mid-domain Tau Antibody Targeting cis-pT231 Tau
errJPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE
IF7.8
err2024-03-01
err6
PREAI
errLuca, Wendy; Foster, K.; McClure, K.; Ahlijanian, M. K.; Jefson, M.
errShare
errSave
Phase 1 Safety and Pharmacodynamic Results of VRDN-001, a Full Antagonist Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R) in Development for Thyroid Eye Disease (TED)
errNEUROLOGY
IF8.5
err2023-04-25
err1
PREAI
errShe, Angela; Katz, Barrett; Summerfelt, Rochelle; O'Shaughnessy, Denis; Dickinson, Brent; Foster, Kelly; Bedian, Vahe
errShare
errSave
Preclinical characterization and IND-enabling safety studies for PNT001, an antibody that recognizes cis-pT231 tau
errALZHEIMERS & DEMENTIA
IF11.1
err2023-04-01
err9
errOAAI
errFoster, Kelly; Manca, Matteo; McClure, Kim; Koivula, Pyry; Trojanowski, John Q.; Havas, Daniel; Chancellor, Sarah; Goldstein, Lee; Brunden, Kurt R.; Kraus, Allison; Ahlijanian, Michael K.
errShare
errSave
Response to Letter to the Editor: Addressing concerns from a recent randomised controlled trial protocol of two acute burn dressings
errBURNS
IF2.9
err2020-02-01
err0
errOAAI
errHolbert, Maleea D.; Griffin, Bronwyn R.; Ware, Robert S.; Foster, Kelly; Kimble, Roy M.
errShare
errSave
Reduced intubation rates for infants after introduction of high-flow nasal prong oxygen delivery
errINTENSIVE CARE MEDICINE
IF21.2
err2011-03-03
err224
errOAAI
errSchibler, A.; Pham, T. M. T.; Dunster, K. R.; Foster, K.; Barlow, A.; Gibbons, K.; Hough, J. L.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
J
John Q. Trojanowski
H-index: 255 · Papers: 1.8K
R
Robert S. Ware
H-index: 70 · Papers: 899
K
Kurt R. Brunden
H-index: 51 · Papers: 203
L
Lee E. Goldstein
H-index: 46 · Papers: 238
R
Roy Kimble
H-index: 46 · Papers: 440
View more